Original Research

Published on 20 Mar 2024

Improvement of social functioning in patients with first-episode schizophrenia using blonanserin treatment: a prospective, multi-centre, single-arm clinical trial

in Schizophrenia

Tianqi Gao
Hong Deng
Jianhua Sheng
Bin Wu
Zhening Liu
Fude Yang
Lina Wang
Shaohua Hu
Xijin Wang
Haiyun Li

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1345978

1,417 views

Original Research

Published on 07 Mar 2024

Methylome-wide and meQTL analysis helps to distinguish treatment response from non-response and pathogenesis markers in schizophrenia

in Schizophrenia

Binithamol K. Polakkattil
Neetha N. Vellichirammal
Indu V. Nair
Chandrasekharan M. Nair
Moinak Banerjee

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1297760

2,002 views

Review

Published on 05 Mar 2024

Treatment of antipsychotic-induced hyperprolactinemia: an umbrella review of systematic reviews and meta-analyses

in Schizophrenia

Qitong Jiang
Tian Li
Lei Zhao
Yue Sun
Zhen Mao
Yujie Xing
Chuanyue Wang
Qijing Bo

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1337274

4,671 views
1 citation

Original Research

Published on 05 Mar 2024

Independent effects of early life adversity on social cognitive function in patients with schizophrenia

in Schizophrenia

Xing Peng
Wen-Peng Hou
Yu-Shen Ding
Qi Wang
Feng Li
Sha Sha
Chen-Chao Yu
Xiu-Jun Zhang
Fu-Chun Zhou
Chuan-Yue Wang

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1343188

1,215 views

Original Research

Published on 05 Mar 2024

Association between increased BMI and cognitive function in first-episode drug-naïve male schizophrenia

in Schizophrenia

Xing Deng
Shuiping Lu
Yan Li
Xinyu Fang
Rongrong Zhang
Xuran Shen
Jinglun Du
Shiping Xie

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1362674

1,282 views
3 citations

Systematic Review

Published on 04 Mar 2024

Neuropsychological dimensions related to alterations of verbal self-monitoring neural networks in schizophrenic language: systematic review

in Schizophrenia

Julián Andrés Guiral

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1356726

1,164 views

Review

Published on 04 Mar 2024

Shared and unique characteristics of metabolic syndrome in psychotic disorders: a review

in Schizophrenia

Luigi F. Saccaro
Alberto Aimo
Giorgia Panichella
Othman Sentissi

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1343427

2,265 views
3 citations

Correction

Published on 29 Feb 2024

Corrigendum: Thinking preferences and conspiracy belief: intuitive thinking and the jumping to conclusions-bias as a basis for the belief in conspiracy theories

in Schizophrenia

Nico Pytlik
Daniel Soll
Stephanie Mehl

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1366548

879 views

Original Research

Published on 27 Feb 2024

Association of SLC6A3 variants with treatment-resistant schizophrenia: a genetic association study of dopamine-related genes in schizophrenia

in Schizophrenia

Masanobu Kogure
Nobuhisa Kanahara
Atsuhiro Miyazawa
Yuki Shiko
Ikuo Otsuka
Koichi Matsuyama
Masayuki Takase
Makoto Kimura
Hiroshi Kimura
Kiyomitsu Ota

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1334335

1,697 views

Original Research

Published on 21 Feb 2024

Patterns of C-reactive protein trends during clozapine titration and the onset of clozapine-induced inflammation: a case series of weekly and daily C-reactive protein monitoring

in Schizophrenia

Yuki Kikuchi
Hiroaki Tanifuji
Sota Ueno
Yoshifumi Onuma
Masatomo Goto
Masato Ishihara
Takeshi Toraiwa
Hiroshi Komatsu
Hiroaki Tomita

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1366621

2,048 views
2 citations

Original Research

Published on 16 Feb 2024

Toxoplasma gondii infection in people with schizophrenia is related to higher hair glucocorticoid levels

in Schizophrenia

Emy Beaumont
Jacques Brodeur
Frédéric Thomas
Antoine M. Dujon
and Consortium Signature
Sonia J. Lupien

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1286135

2,815 views

Brief Research Report

Published on 15 Feb 2024

Psychosocial stress moderates the relationship between cerebrospinal fluid lactate dehydrogenase and the duration of untreated psychosis in first-episode psychosis

in Schizophrenia

Eloi Giné-Servén
Ester Boix-Quintana
Eva Daví-Loscos
Sandra Cepedello
Lara Moreno-Sancho
Marta Niubó
Rebeca Hernández-Antón
Manuel J. Cuesta
Javier Labad

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1327928

1,789 views

Original Research

Published on 15 Feb 2024

Investigating amplitude of low-frequency fluctuation and possible links with cognitive impairment in childhood and adolescence onset schizophrenia: a correlation study

in Schizophrenia

Yinghui Liang
Rongrong Shao
Yanhong Xia
Yadi Li
Suqin Guo

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1288955

1,566 views
1 citation

Original Research

Published on 13 Feb 2024

Exploring global and local processes underlying alterations in resting-state functional connectivity and dynamics in schizophrenia

in Schizophrenia

Christoph Metzner
Cristiana Dimulescu
Fabian Kamp
Sophie Fromm
Peter J. Uhlhaas
Klaus Obermayer

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1352641

1,435 views
1 citation

Opinion

Published on 08 Feb 2024

Neuroinflammation and schizophrenia – is there a link?

in Schizophrenia

Cristiano Chaves
Serdar M. Dursun
Massimo Tusconi
Jaime E. C. Hallak

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1356975

2,386 views
3 citations

Study Protocol

Published on 06 Feb 2024

Valuable interaction with cognitive remediation and optimal antipsychotics for recovery in schizophrenia (VICTORY-S): study protocol for an interventional, open-label, randomized comparison of combined treatment with cognitive remediation and lurasidone or paliperidone

in Schizophrenia

Ryotaro Kubota
Satoru Ikezawa
Hideki Oi
Mari S Oba
Shoki Izumi
Ryoko Tsuno
Leona Adachi
Mako Miwa
Shunji Toya
Yohei Nishizato

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1331356

2,199 views
1 citation

Navigation group

Articles

Improvement of social functioning in patients with first-episode schizophrenia using blonanserin treatment: a prospective, multi-centre, single-arm clinical trial

Methylome-wide and meQTL analysis helps to distinguish treatment response from non-response and pathogenesis markers in schizophrenia

Treatment of antipsychotic-induced hyperprolactinemia: an umbrella review of systematic reviews and meta-analyses

Independent effects of early life adversity on social cognitive function in patients with schizophrenia

Association between increased BMI and cognitive function in first-episode drug-naïve male schizophrenia

Neuropsychological dimensions related to alterations of verbal self-monitoring neural networks in schizophrenic language: systematic review

Shared and unique characteristics of metabolic syndrome in psychotic disorders: a review

Corrigendum: Thinking preferences and conspiracy belief: intuitive thinking and the jumping to conclusions-bias as a basis for the belief in conspiracy theories

Association of SLC6A3 variants with treatment-resistant schizophrenia: a genetic association study of dopamine-related genes in schizophrenia

Patterns of C-reactive protein trends during clozapine titration and the onset of clozapine-induced inflammation: a case series of weekly and daily C-reactive protein monitoring

Toxoplasma gondii infection in people with schizophrenia is related to higher hair glucocorticoid levels

Psychosocial stress moderates the relationship between cerebrospinal fluid lactate dehydrogenase and the duration of untreated psychosis in first-episode psychosis

Investigating amplitude of low-frequency fluctuation and possible links with cognitive impairment in childhood and adolescence onset schizophrenia: a correlation study

Exploring global and local processes underlying alterations in resting-state functional connectivity and dynamics in schizophrenia

Neuroinflammation and schizophrenia – is there a link?

Valuable interaction with cognitive remediation and optimal antipsychotics for recovery in schizophrenia (VICTORY-S): study protocol for an interventional, open-label, randomized comparison of combined treatment with cognitive remediation and lurasidone or paliperidone